AP2858A - Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor - Google Patents

Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor

Info

Publication number
AP2858A
AP2858A AP2011005715A AP2011005715A AP2858A AP 2858 A AP2858 A AP 2858A AP 2011005715 A AP2011005715 A AP 2011005715A AP 2011005715 A AP2011005715 A AP 2011005715A AP 2858 A AP2858 A AP 2858A
Authority
AP
ARIPO
Prior art keywords
diarylpyrimidine
synthesis
reverse transcriptase
nucleoside reverse
transcriptase inhibitor
Prior art date
Application number
AP2011005715A
Other languages
English (en)
Other versions
AP2011005715A0 (en
Inventor
Mukund Keshav Gurjar
Golakchandra Sudarshan Maikap
Shashikant Gangaram Joshi
Original Assignee
Emcure Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd
Publication of AP2011005715A0 publication Critical patent/AP2011005715A0/xx
Application granted granted Critical
Publication of AP2858A publication Critical patent/AP2858A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AP2011005715A 2009-06-22 2010-06-18 Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor AP2858A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1479MU2009 2009-06-22
PCT/IN2010/000422 WO2010150279A2 (en) 2009-06-22 2010-06-18 Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor

Publications (2)

Publication Number Publication Date
AP2011005715A0 AP2011005715A0 (en) 2011-06-30
AP2858A true AP2858A (en) 2014-02-28

Family

ID=43386984

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005715A AP2858A (en) 2009-06-22 2010-06-18 Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor

Country Status (12)

Country Link
US (1) US20110196156A1 (uk)
EP (1) EP2342186B1 (uk)
JP (1) JP5406934B2 (uk)
AP (1) AP2858A (uk)
BR (1) BRPI1004934A2 (uk)
CO (1) CO6430461A2 (uk)
ES (1) ES2527103T3 (uk)
IL (1) IL214862A (uk)
RU (1) RU2556986C2 (uk)
UA (1) UA106972C2 (uk)
WO (1) WO2010150279A2 (uk)
ZA (1) ZA201108690B (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8153790B2 (en) 2009-07-27 2012-04-10 Krizmanic Irena Process for the preparation and purification of etravirine and intermediates thereof
GR1007010B (el) 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
EP2702045B1 (en) 2011-04-26 2017-10-18 Mylan Laboratories Ltd. Novel process for the preparation of etravirine
WO2012170647A1 (en) * 2011-06-09 2012-12-13 Assia Chemical Industriew Ltd. Process for the preparation of etravirine and intermediates in the synthesis thereof
WO2013059572A1 (en) 2011-10-19 2013-04-25 Assia Chemical Industries Ltd. Process for the preparation of etravirine and intermediates in the synthesis thereof
WO2013159286A1 (zh) * 2012-04-24 2013-10-31 上海迪赛诺药业有限公司 依曲韦林及其中间体的制备方法
CN103373965B (zh) * 2012-04-24 2016-04-27 上海迪赛诺药业有限公司 依曲韦林及其中间体的制备方法
CN102675220B (zh) * 2012-05-28 2014-03-19 南京药石药物研发有限公司 一种制备依曲韦林的方法及其中间体
CN104447573B (zh) * 2014-11-27 2016-11-09 山东大学 一种依曲韦林的制备方法
RU2728555C1 (ru) * 2019-12-24 2020-07-30 Общество с ограниченной ответственностью "Балтфарма" Способ получения этравирина
CN111675661B (zh) * 2020-06-28 2021-08-24 山东大学 一种含有反式双键的二芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID28376A (id) * 1998-11-10 2001-05-17 Janssen Pharmaceutica Nv Pirimidina yang menghambat replikasi hiv
TR200200763T2 (tr) * 1999-09-24 2003-09-22 Janssen Pharmaceutica N.V. Antiviral bileşimler
MX2007009015A (es) * 2005-01-27 2007-09-18 Tibotec Pharm Ltd Derivados de 2-(4-cianofenilamino)pirimidina que inhibien el virus de la inmunodeficiencia humana.
US7935711B2 (en) * 2005-02-18 2011-05-03 Tibotec Pharmaceuticals Ltd. HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
DK1858861T3 (da) * 2005-03-04 2010-11-08 Tibotec Pharm Ltd HIV-inhiberende 2-(4-cyanophenyl)-6-hydroxylaminopyrimidiner
WO2008016522A2 (en) * 2006-07-24 2008-02-07 Gilead Sciences, Inc. Hiv reverse transcriptase inhibitors
AR067180A1 (es) * 2007-06-29 2009-09-30 Gilead Sciences Inc Compuestos antivirales
WO2010131118A2 (en) * 2009-05-12 2010-11-18 Pliva Hrvatska D.O.O. Polymorphs of etravirine and processes for preparation thereof

Also Published As

Publication number Publication date
ZA201108690B (en) 2013-01-30
ES2527103T3 (es) 2015-01-20
RU2556986C2 (ru) 2015-07-20
JP2012509314A (ja) 2012-04-19
IL214862A (en) 2015-07-30
WO2010150279A2 (en) 2010-12-29
AP2011005715A0 (en) 2011-06-30
US20110196156A1 (en) 2011-08-11
EP2342186A4 (en) 2012-03-21
WO2010150279A3 (en) 2011-02-24
CO6430461A2 (es) 2012-04-30
JP5406934B2 (ja) 2014-02-05
BRPI1004934A2 (pt) 2016-11-29
RU2011129982A (ru) 2013-01-27
UA106972C2 (uk) 2014-11-10
EP2342186B1 (en) 2014-09-17
IL214862A0 (en) 2011-11-30
EP2342186A2 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
AP2011005715A0 (en) Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor.
BRPI1010624A2 (pt) método para a fabricação de gás de síntese
BRPI1013822A2 (pt) Método para síntese de um trissacarídeo.
SI2510089T1 (sl) Sinteza prazolnih spojin
ZA201102510B (en) Slurry process for synthesis of biophosphites
LT2924034T (lt) Farmacinė kompozicija, apimanti nenukleozidinį atvirkštinės transkriptazės inhibitorių
EG26900A (en) A process for synthesis of methanol
PL2462088T3 (pl) Sposób wytwarzania metanu
IL220106A (en) A method of producing a waterproof gypsum product
LT2462586T (lt) Kalbos sintezės būdas
ZA201100999B (en) Synthesis of a crystalline silicoaluminophosphate
IL218298A0 (en) Synthesis of a neurostimulative piperazine
IL214606A0 (en) Inhibitors of hiv replication
ZA201105709B (en) Process for the synthesis of cleistanthin
IL216202A0 (en) PROCESS FOR THE PREPARATION OF A COMPOUND USEFUL AS AN INHIBITOR OF TAFIa
ZA201107579B (en) A maschine for the expansion of pipes
ZA201200533B (en) Process for the co-production of superheated steam and methane
EP2404400A4 (en) STATE MACHINE OPERATION OF A PROCESS LINKED TO A COVER MODEL
EP2514719A4 (en) PROCESS FOR SYNTHESIS OF AMMONIA
ZA201200348B (en) A process for the synthesis of naratriptan
ZA201107258B (en) Autocatalytic process for the synthesis of chiral proparglic alcohols
ZA201203235B (en) Method fopr increasing the solubility of a transcriptase inhibitor composition
SI2504309T1 (sl) Sinteza acetokslacetaldehida
ZA201201740B (en) Process for the preparation of cathepsin s inhibitors
PL389114A1 (pl) Sposób syntezy prekursorów samoprzylepnego kleju strukturalnego na bazie poliakrylanów